Multimodal Data-Driven Prognostic Model for Predicting Long-Term Prognosis in Patients With Ischemic Cardiomyopathy

Jun Wang1, Yijun Wang2, Shoupeng Duan3

  • 1Department of Cardiology The First Affiliated Hospital of Bengbu Medical University Bengbu Anhui China.

Insights

Machine learning identified key predictors for major adverse cardiovascular events in patients undergoing coronary artery bypass grafting for ischemic cardiomyopathy. This aids in risk stratification for heart failure with preserved ejection fraction.

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering
  • Machine Learning in Healthcare

Background:

  • Limited data exists on coronary artery bypass grafting (CABG) efficacy for ischemic cardiomyopathy with heart failure with preserved ejection fraction (HFpEF).
  • Accurate risk stratification is crucial for optimizing patient selection and outcomes in this complex population.

Purpose of the Study:

  • To develop a machine learning-based prognostic model for risk stratification.
  • To integrate clinical, biomarker, and echocardiography data for enhanced prediction.
  • To improve comprehension of factors influencing outcomes after CABG in ischemic cardiomyopathy with HFpEF.

Main Methods:

  • A cohort of 294 patients with ischemic cardiomyopathy and HFpEF undergoing CABG was analyzed.
  • Least Absolute Shrinkage and Selection Operator (LASSO) regression identified key predictors.
  • A prediction nomogram was constructed using diabetes, hypertension, systemic immune-inflammation index, and NT-proBNP.

Main Results:

  • The nomogram demonstrated satisfactory predictive performance in both development (C-index: 0.768) and validation cohorts (C-index: 0.633).
  • The model showed adequate calibration for predicting major adverse cardiovascular events.
  • Decision curve analysis confirmed the clinical utility of the prognostic model.

Conclusions:

  • A clinically feasible prognostic model was developed using preoperative multimodal data.
  • This model enables effective risk stratification for patients with ischemic heart disease and HFpEF undergoing CABG.
  • The findings support the use of machine learning for personalized risk assessment in cardiovascular surgery.
Abstract